Skip to content

Datamonitor Healthcare Showcases Benefits of Informa's Investment Programme

New York, 9 March 2016: Clients of Datamonitor Healthcare are benefiting from the Informa-wide Growth Acceleration Plan, which includes a $100m+ investment programme that, within Datamonitor Healthcare, has led to a 200% increase in global analyst resources, new cutting-edge sales forecasting tools, and fastest-in-market client support functions - all designed to give clients a competitive edge in the pharmaceutical marketplace.
Datamonitor Healthcare (DMHC) - the market-leading intelligence, analysis, data and information service for the global pharmaceutical industry - forms part of Informa's unrivalled Pharma Intelligence business that also includes Scrip Intelligence, Citeline, BioMedTracker and The Pink Sheet.
"Datamonitor Healthcare offers our clients full analysis - including large scale primary research studies and patient based forecasts - for 68 disease indications and we will continue to expand our offering during 2016 and beyond," explains Linda Blackerby, Head of Pharma Intelligence at Informa. "This is significantly more than any comparable provider and our intelligence represents more than 90% of the value of branded prescription medicine sales in the world's seven major markets."
"We are proud of our unrivalled position as the industry's leading provider of market intelligence, forecasting, data and information, but we are not resting on our laurels," adds Blackerby. "Our use of this Group-wide investment programme - which ensures that DMHC market forecasts are updated in hours or days as opposed to weeks - provides our clients with ever-greater competitive advantage, as they seek to make better decisions, faster."
A key element of DMHC's investment is a state-of-the-art interactive forecasting tool that has been built in collaboration with a leading analytics technology provider. The proprietary forecasting tool puts clients in the driver's seat by providing users with event-driven forecasting updates within 48 hours - weeks, or in some case months, faster than comparable services.
In addition, Pharma Intelligence's raft of support and analyst services provides Datamonitor Healthcare users with immediate answers and direct one-to-one access to experts around the world. 
"Our DMHC Live Support system responds to client queries in minutes and our newly launched Research Concierge™ allows easy, fast and tailored access to resources across the Pharma Intelligence business," says Blackerby. "These services are now available in addition to our highly acclaimed and successful Ask-the-Analyst™ service that puts client in direct contact with our global analyst team."

Datamonitor Healthcare: The Numbers

  • Benefiting from Informa's $100m+ company-wide investment programme
  • Intelligence, data and analysis across 68 disease indications
  • Market intelligence covering more than 90% of the industry in value terms
  • Updated market forecasts in 48 hours -weeks faster than nearest comparable service
  • 200% increase in global analyst resources
  • DMHC Live responds to client queries in minutes; nearest comparable service is hours

"Datamonitor Healthcare is proud to be the market leader in providing intelligence, analysis, data and information for the global pharmaceutical industry," says Blackerby. "Our significant investment in the people, products and services that help our clients make the best decisions for their businesses ensures that we remain the 'must-have' resource for our industry." 

For more information, visit

[websites removed as they no longer exist]

About Informa PLC 

Informa operates at the heart of the Knowledge and Information Economy. It is one of the world's leading business intelligence, academic publishing, knowledge and events businesses. With more than 6,500 employees globally, it has a presence in all major geographies, including North America, South America, Asia, Europe, the Middle East and Africa.